rounded

Na tarde de 22 de dezembro de 2024, a primeira Cúpula Internacional BIOV sobre Tecnologia da Vida e Medicina Regenerativa, organizada pela Fundação AVZ e pela Empresa de Biotecnologia BioV, foi realizada em Bangkok, Tailândia. Esta cimeira reúne os principais académicos, empresários e líderes da indústria do campo global das ciências da vida para se concentrarem nos mais recentes resultados de investigação e nas futuras direções de desenvolvimento da medicina regenerativa e da tecnologia da vida. Mais de cem convidados, incluindo o Príncipe da Tailândia e ganhador do Prêmio Nobel, Professor George F. Smoot, Professor Edvard Moser (online), Professor Thomas C. Sudhof (online), etc., participaram.

 

The Thai royal family prince's speech highlighted the importance of international cooperation.

 

 

The Thai royal family prince delivered an opening speech, warmly welcoming all professors and guests gathered in Bangkok. He fully affirmed the achievements of the global medical community in the field of regenerative medicine and emphasized the importance of international cooperation in promoting progress in life sciences, hoping that this summit would contribute to global healthcare.

 

AVZ Foundation: Promoting innovation in life sciences through capital

 

 

AVZ基金会 CEO Viviana 女士在开幕式上发表中英文致辞,代表 AVZ 基金会及 BIOV 生物科技公司,对与会嘉宾的支持表示热烈欢迎。她指出,生命科学领域处于解决人类重大挑战的前沿,而科学技术的普惠化是关键目标。AVZ基金会始终秉承创新驱动理念,通过资本连接全球资源,支持颠覆性技术与企业发展。她还宣布,基金未来将推出更多与慈善相关的创意计划,把收益的一部分投入科研事业,为人类健康事业贡献力量。

 

Professor George F. Smoot: The future possibilities of stem cells

 

 

 

Nobel Prize in Physics laureate and 'father of stem cells' Professor George F. Smoot delivered an academic speech titled 'Stem Cell Centers and the Automation and Safety of Treatment.' He analyzed the vast space of the stem cell market from a global treatment layout perspective and reviewed the significant achievements in stem cell research. He posed a key question to the attendees—what kind of transformation will stem cells bring in the future? Professor Smoot expressed that it was extremely meaningful to be present on Christmas Eve, sharing insights with experts and scholars from various fields.

 

Professor Edvard Moser: Cell research and the prospects for treating Alzheimer's disease

 

 

Nobel Prize in Physiology or Medicine laureate Professor Edvard Moser focused his speech on the importance of cell research in the treatment of Alzheimer's disease. He pointed out that Alzheimer's disease is particularly common among the elderly, and the research on cell localization systems has profound significance for overcoming this challenge.

 

Professor Thomas C. Sudhof: The broad applications of stem cell-derived technologies

 

 

Nobel Prize in Medicine laureate Professor Thomas C. Sudhof explored the potential of stem cell-derived cells as tools for understanding diseases. He stated that these technologies may be widely used in regenerative medicine in the future, providing new avenues for addressing significant social health issues.

 

Dr. Yan Ying: The application of TILS cells in advanced colorectal cancer

 

 

Dr. Yan Ying from Fudan University School of Medicine shared the breakthrough progress in TILS cell preparation and its clinical application in advanced colorectal cancer. He elaborated on three milestone achievements in tumor research, providing new possibilities and perspectives for cell therapy.

 

Dr. Chen Lin: Ensuring the safety and stability of NK cell culture

 

 

Dr. Chen Lin, a PhD from Boston University and a postdoctoral researcher at Harvard University, focused his speech on the application of nourishing cell methods in NK cell culture. He pointed out that scientific verification shows that NK cells have good safety and no tumorigenesis risk, providing a reliable foundation for future cell therapy.

 

Dr. Shi Lin: Cell therapy opens a new era in medicine

 

 

Dr. Shi Lin from Queen Mary University of London and Beijing Nosaki Genomic Research Center proposed that the 20th century was the era of drug therapy, while the 21st century is the era of cell therapy. Through numerous examples, he demonstrated the broad prospects of cell therapy in the medical field and defined it as a new star in biomedicine.

 

Chairman Sun Xin: The construction of the Health Island concept

 

 

Chairman Sun Xin of Zhongjian Group proposed the concept of a 'Health Island,' emphasizing the creation of a comprehensive health management system within the BIOV ecosystem through new products and technologies, pioneering a new model for human health.

 

Dr. Ma Lixin: Cell technology aids in the cure of chronic diseases and malignant tumors

 

 

Dr. Ma Lixin, a medical doctor from Tongji University, summarized the practical cases of BioV biotechnology in the clinical cure of chronic diseases and malignant tumors. He emphasized that modern cell technology can not only treat diseases but also extend life, bringing new breakthroughs to medical research.

 

Chairman of the AVZ Foundation summarized his speech: Conveying the belief in the future

 

Finally, Mr. Yu, chairman of the AVZ Foundation, delivered a concluding speech. He expressed gratitude for the support of the guests and conveyed a firm belief in the future development of life sciences. Mr. Yu stated that the AVZ Foundation will continue to promote international cooperation and contribute to the development of regenerative medicine and life technology.

This summit provided a high-level communication platform for the global life sciences field, further highlighting the important role of the BIOV project in global health.